PBC Research

Anti-depressant may help PBC

A new study from the University of Calgary shows the antidepressant, Mitrazapine, may help PBC. In April  Dr Abdel Aziz presented the promising results. Read more here.

Read More »

Ursodeoxycholic Acid – there is no such thing as non-response

At the AASLD 2017 Liver Meeting, an abstract was presented, by Dr. van der Meer et al  titled “Ursodeoxycholic Acid is Associated with Prolonged Transplant-free Survival in All Patients with Primary Biliary Cholangitis – there is no such thing as non-response”  Read an article discussing the abstract in MedPage Today

Read More »

Difference between PBC & PSC

At the AASLD Liver Meeting 2017, PSC Partners presented this great info graphic that helps explain the differences between PSC Primary Sclerosing Cholangitis and PBC- Primary Biliary Cholangitis.  Connect to PSC Partners Seeking a Cure to read more

Read More »

New Canadian PBC Patient Registry

In 2016, we designated the proceeds of the Canadian PBC Society’s signature fundraising event, A Day at the Races, to support PBC education, awareness and research at the Toronto Centre for Liver Disease.   More than $11,000 was raised through the event and these funds have now been committed to

Read More »

New European Guidelines for PBC Diagnosis and Treatment

In March 2017 New European Guidelines for PBC Diagnosis and Treatment were published. We are very excited that these guidelines include ensuring that patients have access to PBC Patient Support Groups like ours. Looking forward to seeing new similar North American Guidelines. Read full article.  

Read More »

PBC Prevalence Study released

See the first Canadian PBC Prevalence study published March, 2017. The objectives of this study were to estimate and characterize the PBC population and associated PBC liver transplant recipients across Canada.   The study: Estimates the prevalence of PBC Describes the PBC patient population Estimates the prevalence of PBC liver

Read More »